Zhanna Jumadilova

Corporate Officer/Principal at CLARUS THERAPEUTICS HOLDINGS, INC.

Health Technology

Consumer Services

Profile

Zhanna Jumadilova is currently the Chief Clinical Development Officer at Clarus Therapeutics Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Insmed, Inc. from 2019 to 2021.
He also worked at AstraZeneca, Inc. as a General Manager.
Jumadilova holds an MBA from Joseph M.
Katz Graduate School of Business and a doctorate from Kazakh National Medical University.

Zhanna Jumadilova active positions

Companies	Position	Start
CLARUS THERAPEUTICS HOLDINGS, INC.	Corporate Officer/Principal	2022-01-16

All active positions of Zhanna Jumadilova

Former positions of Zhanna Jumadilova

Companies	Position	End
INSMED INCORPORATED	Corporate Officer/Principal	2021-09-30
AstraZeneca, Inc. AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines	Corporate Officer/Principal	-

See the detail of Zhanna Jumadilova's experience

Training of Zhanna Jumadilova

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zhanna Jumadilova's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Insmed, Inc. Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases	Health Technology
AstraZeneca, Inc. AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines	Health Technology
Joseph M. Katz Graduate School of Business Joseph M. Katz Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kazakh National Medical University Kazakh National Medical University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies	Health Technology